Evidence map›Paper›PMID 41332911›Full record

ReviewJugan geon-gang gwa jilbyeong2024

[Global Measles Outbreaks].

Ju-Young Sim, Jae-Hwa Chung, Ji-Young Oh, Jee-Eun Yi, Yun-Hee Lee, Si-Won Choi, Ji-A Lee, Yeo-Won Jin, Hyo-Soon Yoo

Abstract readEnglish AbstractReview
In one paragraph

Review in Jugan geon-gang gwa jilbyeong, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ju-Young Sim질병관리청 위기대응분석관 위기분석담당관.
Jae-Hwa Chung질병관리청 위기대응분석관 위기분석담당관.
Ji-Young Oh질병관리청 위기대응분석관 위기분석담당관.
Jee-Eun Yi질병관리청 위기대응분석관 위기분석담당관.
Yun-Hee Lee질병관리청 위기대응분석관 위기분석담당관.
Si-Won Choi질병관리청 위기대응분석관 위기분석담당관.
Ji-A Lee질병관리청 위기대응분석관 위기분석담당관.
Yeo-Won Jin질병관리청 위기대응분석관 위기분석담당관.
Hyo-Soon Yoo질병관리청 위기대응분석관 위기분석담당관.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2023, as public health and social measures due to coronavirus disease 2019 (COVID-19) eased and overseas travel resumed, measles cases increased rapidly worldwide. According to the World Health Organization (WHO), approximately 320,000 measles cases were reported worldwide in 2023, 1.8 times higher than approximately 170,000 cases in 2022. Even in countries verified as measles-eradication countries, community epidemics have been observed mainly among unvaccinated and incompletely vaccinated people. The WHO indicated that low vaccination rates and increased international travel are the main causes of the rapid increase in measles outbreaks. During the COVID-19 pandemic, vaccination services were suspended or delayed in many countries, significantly decreasing vaccination rates. Simultaneously, as travel restrictions eased, population movement increased worldwide, creating an environment that made it easy for the measles virus to spread to various regions. The WHO has set the goal of eradicating measles by 2030, and important strategies include maintaining and strengthening vaccination rates, strengthening quarantine, patient surveillance, public health education, and information sharing through international cooperation. As of 2022, the Republic of Korea has maintained a relatively high vaccination rate by meeting the standards for maintaining herd immunity of over 95% recommended by the WHO, with a secondary vaccination rate of 95%. However, there is a risk of transmission through certain age groups and overseas inflows where vaccination rates are relatively low. Therefore, in areas with an active measles outbreak, it is essential to be vaccinated before traveling to areas where outbreaks are increasing, and careful monitoring is necessary to prevent domestic inflow.

Indexed as

MeaslesOverseas importationVaccinationWorld Health Organization

Identifiers

PMID41332911
PMCPMC12480071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.